The Problem with Copay Coupons

October 17, 2016
Health Care, Management




Copay coupons for Epipen and other expensive medicines save patients money up front, but Professor Peter Ubel explains why they cost everyone more in the long run, and what pharmaceutical companies should do instead. Ubel expanded on these ideas in a paper in the Annals of Internal Medicine.

This story may not be republished without permission from Duke University's Fuqua School of Business. Please contact for additional information.

Contact Info

For more information contact our media relations team at